| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/01/2010 | US20100166809 Methods of treating or preventing biofilm associated infections with free available chlorine free available chlorine water |
| 07/01/2010 | US20100166808 Method of Facilitating Intracellular Uptake or Transcellular Transport of Cargo Using Nanocarriers Containing Optimal Surface Densities of Integrin-Specific Ligands |
| 07/01/2010 | US20100166807 Methods for reducing the incidence of mastitis |
| 07/01/2010 | US20100166806 Combination therapy comprising the use of protein kinase C modulators and Histone Deacetylase inhibitors for treating HIV-1 latency |
| 07/01/2010 | US20100166677 Use of Tiliacora Triandra in Cosmetics and Compositions Thereof |
| 07/01/2010 | US20100166676 RNAi-MEDIATED INHIBITION OF TUMOR NECROSIS FACTOR ALPHA-RELATED CONDITIONS |
| 07/01/2010 | US20100166675 Pharmaceutical Composition for the Treatment of Type 1-Diabetes |
| 07/01/2010 | US20100166674 Transdermal delivery rate control using amorphous pharmaceutical compositions |
| 07/01/2010 | US20100166673 Aerosolized fluoroquinolones and uses thereof |
| 07/01/2010 | US20100166672 Foam-forming composition |
| 07/01/2010 | US20100166671 Organic compounds |
| 07/01/2010 | US20100166670 Use of boswellic acid and its derivatives for inhibiting normal and increased leucocytic elastase or plasmin activity |
| 07/01/2010 | US20100163071 Silicone and siloxane-based impregnated coating and polymeric materials for conditioning |
| 07/01/2010 | CA2848666A1 Coating material for solid medicine and solid medicine formed with the same |
| 07/01/2010 | CA2780485A1 Nasal formulations of metoclopramide |
| 07/01/2010 | CA2750371A1 Dry powder pharmaceutical composition for inhalation |
| 07/01/2010 | CA2748346A1 Use of a foamable composition essentially free of pharmaceutically active ingredients for the treatment of human skin |
| 07/01/2010 | CA2748296A1 Implantable composites and compositions comprising releasable bioactive agents |
| 07/01/2010 | CA2748195A1 Pressure-sensitive adhesive tape package |
| 07/01/2010 | CA2748155A1 Enema preparations and their use |
| 07/01/2010 | CA2747998A1 Safe desmopressin administration |
| 07/01/2010 | CA2747955A1 Implantable devices for treating hiv |
| 07/01/2010 | CA2747939A1 A composition and method of treating skin conditions. |
| 07/01/2010 | CA2747917A1 Compositions of topical ocular solutions to deliver effective concentrations of active agent to the posterior segment of the eye |
| 07/01/2010 | CA2747318A1 Inflammation targeting particles |
| 07/01/2010 | CA2746985A1 Preparation method of polymeric micellar nanoparticles composition containing a poorly water-soluble drug |
| 07/01/2010 | CA2746983A1 Preparation method of polymeric micelles composition containing a poorly water-soluble drug |
| 07/01/2010 | CA2746887A1 Methods for enhancing the release and absorption of water insoluble active agents |
| 07/01/2010 | CA2745557A1 Process for the preparation of a peptide powder form |
| 07/01/2010 | CA2745457A1 Topical pharmaceutical composition containing a water-sensitive active principle |
| 07/01/2010 | CA2745034A1 Ceramic honeycomb structure skin coating |
| 07/01/2010 | CA2744008A1 Coating material for solid medicine and solid medicine formed with the same |
| 07/01/2010 | CA2735968A1 Method for producing liposome and method for dissolving cholesterol |
| 07/01/2010 | CA2732686A1 Controlled release auris sensory cell modulator compositions and methods for the treatment of otic disorders |
| 06/30/2010 | EP2202229A1 Novel preparation for external use |
| 06/30/2010 | EP2201964A2 Formoterol superfine formulation |
| 06/30/2010 | EP2201956A1 Granular jelly beverage for medication and process for producing the same |
| 06/30/2010 | EP2201952A1 Omeprazole dosage forms and their use |
| 06/30/2010 | EP2201942A1 Compound with hemp oil for the treatment of topical illnesses |
| 06/30/2010 | EP2201941A1 Plaster production technology |
| 06/30/2010 | EP2201940A1 Composition of biocompatible microparticles of alginic acid for the controlled release of active ingredients by intravenous administration |
| 06/30/2010 | EP2201939A1 Method for producing coated spiramycin and novel formulations containing the same |
| 06/30/2010 | EP2201938A1 Controllable drug delivery capsule |
| 06/30/2010 | EP2201937A1 Formulations comprising vitamin D or derivatives thereof |
| 06/30/2010 | EP2201936A1 Method of treating acute rhinosinusitis |
| 06/30/2010 | EP2201935A1 Polymeric micelle composition containing a poorly soluble drug and preparation method of the same |
| 06/30/2010 | EP2201934A1 Tiotropium aerosol formulation products with improved chemical stability |
| 06/30/2010 | EP2201930A1 Hydrogel composition for the treatment of dermatological disorders |
| 06/30/2010 | EP2201053A1 Graft copolymers as drug delivery systems |
| 06/30/2010 | EP2200659A2 Use of lanthanide-based nanoparticles as radiosensitizing agents |
| 06/30/2010 | EP2200617A1 Improved brimonidine compositions for treating erythema |
| 06/30/2010 | EP2200602A1 Controlled release tamsulosin hydrochloride tablets and a process of making them |
| 06/30/2010 | EP2200594A1 Oral dosage combination pharmaceutical packaging |
| 06/30/2010 | EP2200593A1 Abuse resistant drug formulation |
| 06/30/2010 | EP2200592A2 Adhering troches with topically active ingredients for treatment of throat, esophagus, and stomach |
| 06/30/2010 | EP2200591A2 Controlled release pharmaceutical dosage forms of trimetazidine |
| 06/30/2010 | EP2200589A2 Compositions and methods for treating post-operative pain using clonidine and bupivacaine |
| 06/30/2010 | EP2200588A1 Compositions comprising lipophilic active compounds and method for their preparation |
| 06/30/2010 | EP2200587A1 Dry powders of cellular material |
| 06/30/2010 | EP2200586A2 Improved liposomes and uses thereof |
| 06/30/2010 | EP2200584A2 Formulation containing cyclin-dependent kinase inhibiting compound and method of treating tumors using the same |
| 06/30/2010 | EP2200583A1 Stable formulations of amylin and its analogues |
| 06/30/2010 | EP2200582A2 Use of carriers as preservatives and pharmaceutical composition containing same |
| 06/30/2010 | EP2200581A2 Steroid containing ophthalmic drug delivery systems |
| 06/30/2010 | EP2200580A2 Method for the immobilization of bioactive molecules within a polymeric substrate resistant to the stomach acids as oral drug delivery system |
| 06/30/2010 | EP2200579A2 Antiviral topical formulations in the form of a bio-adhesive gel |
| 06/30/2010 | EP2200578A1 Cytocompatible alginate gels |
| 06/30/2010 | EP2200570A2 Microcapsules and methods |
| 06/30/2010 | EP2200569A1 Kit for care of foot and/or hand |
| 06/30/2010 | EP2200566A1 Improved topical pain relief product |
| 06/30/2010 | EP1682552B1 Tocopherol-modified therapeutic drug compounds |
| 06/30/2010 | EP1545548B1 The use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis |
| 06/30/2010 | EP1534252B1 Breath freshening and oral cleansing product using cardamom oil |
| 06/30/2010 | EP1366760B1 Tablets quickly disintegrated in oral cavity |
| 06/30/2010 | EP1332366B1 Methods for the Assessment of Cellular Proliferative Disorders |
| 06/30/2010 | EP1284727B1 Intracorporeal medicaments for photodynamic treatment of disease |
| 06/30/2010 | CN201516175U Empladstrum |
| 06/30/2010 | CN1977926B Application of ampelopsis for preparing medicine for promoting wound quick healing |
| 06/30/2010 | CN1911442B Lysostaphin freeze dried powder used for preventing and treating trauma surface infestation |
| 06/30/2010 | CN1895408B Radix saposhnikoviae Tong Sheng capsules, preparation and quality control method thereof |
| 06/30/2010 | CN1895259B Preparation of injection for treating cardiovascular disease |
| 06/30/2010 | CN1781479B Chinese small iris seed agent dispersion system and its preparing method |
| 06/30/2010 | CN101765426A Amino-acid-containing medicinal granular preparation highly easy to take |
| 06/30/2010 | CN101765423A Nucleic acid nanoparticles and uses therefor |
| 06/30/2010 | CN101765422A Locally administrated low doses of corticosteroids |
| 06/30/2010 | CN101758961A Patch package structure |
| 06/30/2010 | CN101757632A Soft capsule shell composition and application thereof |
| 06/30/2010 | CN101757629A Medicine composition for treating acute and chronic aryngitis and preparation method thereof |
| 06/30/2010 | CN101757615A Ointment for clearing nose planted staphylococcus aureus and preparing method thereof |
| 06/30/2010 | CN101757611A Gama-interferon dry-powder inhaler for chickens and preparation method thereof |
| 06/30/2010 | CN101757609A Method for controlling residue of organic solvent in thymic peptide alpha1 microballoon |
| 06/30/2010 | CN101757603A Medicinal composition containing trandolapril taste-masking composition |
| 06/30/2010 | CN101757600A External application ointment for treating hyperosteogeny and rheumatoid arthritis and preparation method thereof |
| 06/30/2010 | CN101757595A Traditional Chinese medicine composition for treating vomiting of pregnancy and preparation method thereof |
| 06/30/2010 | CN101757594A Pharmaceutical composite for preventing and curing infertility of female and preparation method and use thereof |
| 06/30/2010 | CN101757590A Ointment for treating frostbite |
| 06/30/2010 | CN101757586A Preparation method of fructus psoraleae tuckahoe lotus seed pills |
| 06/30/2010 | CN101757571A Externally-applied traditional Chinese medicine composition for treating brain tumor and preparation method thereof |
| 06/30/2010 | CN101757555A Capsule for treating pharyngitis |
| 06/30/2010 | CN101757554A Granular painkiller |